Crossref
Caffeine and neurodegenerative diseases
Pharmacotherapy in Psychiatry and Neurology · 2025 · 41 (2) · 133-139
DOI: 10.5114/fpn.2025.159502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2025. Verfasst von Adam Łabuda und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Łabuda, A., Tokarczyk, E., Ziemińska, D., Burczyk, R., Bentkowska, Z., Kuciński, J., Górna, N., Bugajewski, M., Bogoń, A., & Stępień, A. (2025). Caffeine and neurodegenerative diseases. Pharmacotherapy in Psychiatry and Neurology, 41(2), 133-139. https://doi.org/10.5114/fpn.2025.159502
Vancouver
Łabuda A, Tokarczyk E, Ziemińska D, Burczyk R, Bentkowska Z, Kuciński J, et al. Caffeine and neurodegenerative diseases. Pharmacotherapy in Psychiatry and Neurology. 2025;41(2):133-139. doi:10.5114/fpn.2025.159502
BibTeX
@article{abuda2025,
author = {Łabuda, Adam and Tokarczyk, Elżbieta and Ziemińska, Daria and Burczyk, Rafał and Bentkowska, Zuzanna and Kuciński, Jakub and Górna, Natalie and Bugajewski, Maciej and Bogoń, Aleksandra and Stępień, Alicja},
title = {Caffeine and neurodegenerative diseases},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2025},
volume = {41},
number = {2},
pages = {133--139},
doi = {10.5114/fpn.2025.159502}
}
EUVIMED